← Back to Influence Map
Inflation Reduction Act - Drug Pricing Provisions (H.R.5376)
EnactedFirst-ever Medicare drug price negotiation authority. Starting in 2026, Medicare can negotiate prices for 10 high-cost drugs, expanding to 20 by 2029. Also caps insulin at $35/month for Medicare beneficiaries and requires manufacturers to pay rebates if prices rise faster than inflation.
Who took a position
Supporting and opposing lists hold cited positions only. Lobbying filings say an entity lobbied on the measure, not which way. Positions the ingest inferred from donations are not positions and are listed separately below as giving to the legislators who voted.
Lobbied on (102)
- AVANGRID INC
- INT'L ASSNHEAT&FROST INSULATORS ALLIED WORKERSLABOR MANAGEMENT COOPERATIVE TRUST
- GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI)
- FEDERAL EXPRESS CORPORATION
- NATIONAL COUNCIL OF FARMER COOPERATIVES
- O'NEAL INDUSTRIES
- CENTERPOINT ENERGY, INC.
- CIGNA CORPORATION
- ELECTRIC HYDROGEN
- NATIONAL GRID USA SERVICE COMPANY, INC. D/B/A NATIONAL GRID
- T-MOBILE
- SHIPPING TAXATION COALITION (INFORMAL COALITION)
- and 90 more
Supporting (1)
Opposing (0)
- No opposing positions recorded.